Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions
Generated Narrative: SubstanceDefinition
Resource SubstanceDefinition "substance-dolutegravirsodium"
Profile: SubstanceDefinition (ePI)
identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//1Q1V9V5WYQ (use: OFFICIAL)
version: 1
status: Active (PublicationStatus#active)
manufacturer: Organization/man-173fde4cb6b1018cb7ec8ab708d3961c "GLAXO WELLCOME, S.A."
| Type | Amount |
| exact () | 441.36 |
| MolecularFormula |
| C20H18F2N305.Na |
| Name | Type |
| (4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE | Chemical Name (#x) |